Skip to main content
Molecular Partners AG logo

Molecular Partners AG — Investor Relations & Filings

Ticker · MOLN ISIN · CH0256379097 LEI · 875500AXMLDAZ4D21744 SW Manufacturing
Open in API
Filings indexed 113 across all filing types
Latest filing 2026-06-01 Regulatory Filings
Country CH Switzerland
Listing SW MOLN

About Molecular Partners AG

https://www.molecularpartners.com/

Molecular Partners AG is a clinical-stage biopharmaceutical company pioneering the design and development of a novel class of protein therapeutics known as DARPin® therapies. DARPins (Designed Ankyrin Repeat Proteins) are a proprietary class of small, custom-built proteins engineered to bind to specific disease targets with high potency and specificity. The company leverages its platform to create multi-specific drug candidates capable of engaging multiple targets or pathways simultaneously. The development pipeline is primarily focused on advancing innovative treatments in oncology, with clinical programs targeting serious diseases such as acute myeloid leukemia (AML). The company's approach aims to address complex medical challenges by utilizing the unique properties of its engineered protein platform.

Recent filings

Filing Released Lang Actions
FORM 6-K
Regulatory Filings Classification · 90% confidence The document is a Form 6-K filing by a foreign private issuer with the SEC, providing a press release as an exhibit. It is a regulatory submission rather than a full financial report, earnings release, or management commentary. There is no financial data or substantive report content beyond the exhibit reference, so it falls into the general “Regulatory Filings” category under SEC compliance. Thus, the correct classification is Regulatory Filings (RNS).
2026-06-01 English
6-K - MOLECULAR PARTNERS AG (0001745114) (Filer)
Regulatory Filings Classification · 95% confidence The document is a Form 6-K filed by a foreign private issuer, Molecular Partners AG, pursuant to SEC rules. It references a press release dated May 1, 2026, attached as Exhibit 99.1. The document length is only 2501 characters, indicating it is a short filing. The text does not contain any substantive financial data or detailed report content but rather serves as a notification and attachment of a press release. According to the 'Menu vs Meal' rule, such short filings that announce or attach other documents without containing the full report themselves should be classified as Regulatory Filings (RNS). Therefore, this document is best classified as a Regulatory Filing (RNS).
2026-05-01 English
6-K - MOLECULAR PARTNERS AG (0001745114) (Filer)
Regulatory Filings Classification · 95% confidence The document is a Form 6-K filed by a foreign private issuer, Molecular Partners AG, with the SEC. It includes a press release dated April 14, 2026, attached as Exhibit 99.1. The document length is 2512 characters, which is relatively short and primarily serves as a regulatory filing to disclose the press release. There is no substantive financial data, detailed report, or comprehensive analysis included. The document is not an annual report, earnings release, or any detailed financial or management report. It is a regulatory filing to announce the press release, consistent with the nature of Form 6-K filings. Therefore, the appropriate classification is Regulatory Filings (RNS).
2026-04-14 English
6-K - MOLECULAR PARTNERS AG (0001745114) (Filer)
AGM Information Classification · 95% confidence The document is an invitation to the Annual General Meeting (AGM) of Molecular Partners AG for the year 2026. It includes details about the meeting date, location, agenda items, and the nomination of a new board member. It also contains a financial calendar with upcoming reporting dates. The document does not contain financial statements or detailed financial performance data, but rather serves as a notice and invitation to the AGM along with related board nomination information. This fits the definition of AGM Information (AGM-R), which includes presentations and materials shared during the AGM or invitations to it. The document length is 7,719 characters, which is sufficient for an AGM invitation and related information. Therefore, the correct classification is AGM Information (AGM-R).
2026-03-30 English
6-K Filing
Regulatory Filings Classification · 95% confidence The document is a Form 6-K filed with the SEC by a foreign private issuer, Molecular Partners AG, for the month of February 2026. It references an attached press release dated February 2, 2026, but does not contain substantive financial data or detailed report content itself. The document length is only 2490 characters, which is short and consistent with an announcement or filing notice rather than a full report. According to the rules, Form 6-K filings are regulatory filings used to furnish reports or documents required by the issuer's home country laws or exchange rules. Since this document is primarily a cover form referencing an attached press release and does not contain the report itself, it fits best under Regulatory Filings (RNS).
2026-02-02 English
FORM 6-K
Regulatory Filings Classification · 95% confidence The document is a Form 6-K filed by a foreign private issuer, Molecular Partners AG, pursuant to SEC rules. It includes a press release as Exhibit 99.1 but does not contain detailed financial statements or substantive financial data. The document length is only 2520 characters, which is short and consistent with an announcement or regulatory filing rather than a full report. The text states that the press release is attached and incorporated by reference, indicating this is a filing to provide information rather than the report itself. Therefore, this document fits the category of Regulatory Filings (RNS), which is the fallback for miscellaneous SEC filings like Form 6-K that do not fit other categories.
2026-01-12 English

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.